M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.
about
Innovative Therapeutics: Designer Natriuretic Peptides.The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure.Natriuretic Peptides as a Novel Target in Resistant Hypertension.From bedside to bench--meeting report of the 7th International Conference on cGMP "cGMP: generators, effectors and therapeutic implications" in Trier, Germany, from June 19th to 21st 2015.Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodelingSynthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.MANP: a novel particulate guanylyl cyclase A receptor/cGMP activator for resistant hypertension: preliminary first in human clinical trial results.
P2860
Q33653332-EE832ACD-12C4-4AC2-92BC-D32418659371Q37583865-0A0A5659-5D65-4BCD-80D7-B353D1A891D9Q38261513-B0536037-C0B6-4C2C-A216-22FC94B9A659Q38371173-167976D5-6F6A-4CC5-98C1-EBC6C972228FQ38612665-8C014662-8C16-4F16-9187-51ADA2D17E3BQ41968416-4449C8E7-7D44-45CA-9DB8-1B7B5807A3C7Q47855200-A1A46222-72CB-4043-90A7-ACC99E4B57A3Q50353040-86F74F2E-87E3-4176-A5EB-3D93F2753279
P2860
M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
M-atrial natriuretic peptide a ...... cGMP activating therapeutics.
@en
M-atrial natriuretic peptide a ...... cGMP activating therapeutics.
@nl
type
label
M-atrial natriuretic peptide a ...... cGMP activating therapeutics.
@en
M-atrial natriuretic peptide a ...... cGMP activating therapeutics.
@nl
prefLabel
M-atrial natriuretic peptide a ...... cGMP activating therapeutics.
@en
M-atrial natriuretic peptide a ...... cGMP activating therapeutics.
@nl
P2093
P2860
P356
P1476
M-atrial natriuretic peptide a ...... cGMP activating therapeutics.
@en
P2093
Alessandro Cataliotti
Horng H Chen
John C Burnett
Paul M McKie
S Jeson Sangaralingham
Tomoko Ichiki
P2860
P304
P356
10.1161/JAHA.113.000206
P577
2014-01-02T00:00:00Z